Karyotype in acute myeloblastic leukemia: Prognostic significance for bone marrow transplantation in first remission: A European Group for Blood and Marrow Transplantation Study

Blood

Volumn 90, Issue 8, 1997, Pages 2931-2938

  Ferrant, A ^a   Labopin, M ^b   Frassoni, F ^b   Prentice, H G ^b   Cahn, J Y ^b   Blaise, D ^b   Reiffers, J ^b   Visani, G ^b   Sanz, M A ^b   Boogaerts, M A ^b   Lowenberg B ^b   Gorin, N C ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIPLOIDY; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; EUROPE; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION;

EID: 0030762673     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei III E: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896, 1994
2. Laporte JPh, Douay L, Lopez M, Labopin M, Jouet JP, Stachowiak J, Isnard F, Noel-Walter MP, Pene F, Bauters F, Najman A, Gorin NC: One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: A 10-year single institution experience. Blood 84:3810, 1994
3. Gorin NC: Stem cell transplantation in acute leukemia. Ann NY Acad Sci 770:262, 1995
4. Gorin NC, Labopin M, Meloni G, Körbling M, Carella A, Hervé P, Burnett A, Rizzoli V, Alessandrino EP, Björkstrand B, Ferrant A, Löwenberg B, Coser P, Simonsson B, Helbig W, Brunet-Mauri S, Verdonck LF, Iriondo A, Polli E, Colombat Ph, Franklin IM, Souillet G, Willemze R: Autologous bone marrow transplantation for acute myelocytic leukemia in Europe. Further evidence of the role of marrow purging by mafosfamide. Leukemia 5:896, 1991
5. Löwenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, de Planque M, Abels J, Sonneveld P, van der Lelie J, Goudsmit R, van Putten WLJ, Sizoo W, de Gast GC: Autologous bone marrow transplantation in acute myeloid leukemia in first remission: Results of a Dutch prospective study. J Clin Oncol 8:287, 1990
6. Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217, 1995
7. Champlin RE, Ho WG, Gale RP, Winston D, Selch M, Mitsuyasu R, Lenarsky C, Elashoff R, Zighelboim J, Feig SA: Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 102:285, 1985
8. Appelbaum FR, Fisher LD, Thomas ED, and the Seattle Marrow Transplant Team: Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: A five-year follow-up. Blood 72:179, 1988
9. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ: Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome. Leukemia 2:403, 1988
10. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263, 1989
11. Stasi R, Del Poeta G, Masi M, Tribalto M, Venditti A, Papa G, Nicoletti B, Vernole P, Tedeschi B, Delaroche I, Mingarelli R, Dallapiccola B: Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genet Cytogenet 67:28, 1993
12. Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G, Kreiner G, Wagner B, Lechner K, Lutz D, Bettelheim P, Haas OA: Prognostic impact of karyotype and immunologic phenotype in 125 patients with de novo AML. Cancer Genet Cytogenet 61:14, 1992
13. Fenaux P, Preudhomme C, Laï JL, Morel P, Beuscart R, Bauters F: Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: A report on 283 cases. Br J Haemat 73:61, 1989
14. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA, Mayer RJ: Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood 84:111a, 1994 (abstr, suppl)
15. Burnett AK, Goldstone AH, Stevens RF, Hann IM, Rees JK, Wheatley K, Gray RG: The role of BMT in addition to intensive chemotherapy in AML in first CR: Results of the MRC AML-10 trial. Blood 84:252a, 1994 (abstr, suppl)
16. Ferrant A, Doyen C, Delannoy A, Straetmans N, Martiat P, Mineur P, Bosly A, Van den Berghe H, Michaux JL: Karyotype in acute myeloblastic leukemia: Prognostic significance in a prospective study assessing bone marrow transplantation in first remission. Bone Marrow Transplant 15:685, 1995
17. Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson K, Babu R, Dicke KA, Klein JP, Löwenberg B, Reiffers J, Rimm AA, Rowlings PA, Sandberg AA, Sobocinski KA, Veum-Stone J, Bortin MM: Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 16:203, 1995
18. Arthur DC, Berger R, Golomb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW, Garson OM, Hagemeijer A, Kaneko Y, Mitelman F, Pierre RV, Ruutu T, Sakurai M, Lawler SD, Rowley JD: The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 40:203, 1989
19. Mandelli F, Labopin M, Granena A, Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J, Gratwohl A, Gorin NC: European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Bone Marrow Transplant 14:293, 1994
20. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80:2176, 1992
21. Vahdat L, Maslak P, Miller WH, Eardley A, Heller G, Scheinberg DA, Warrell RP: Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PMN/RAR isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843, 1994
22. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R: Antileukemia effect of graft versus host disease in human recipients of allogeneic grafts. N Engl J Med 300:1068, 1979
23. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
24. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft versus leukemimia reactions following bone marrow transplantation in humans. Blood 75:555, 1989
25. Maruyama F, Yang P, Stass CA, Cork A, Freireich EJ, Lee MS, Chang KS: Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia. Cancer Res 53:4449, 1993
26. Caligiuri MA, Schichman SA, Strout MP, Mrozek K, Baer MR, Frankel SR, Barcos M, Herzig GP, Croce CM, Bloomfield CD: Molecular rearrangement of the ALL1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res 54:370, 1994
27. Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M: Long-term survival in acute myelogenous leukemia: A second follow-up of the fourth international workshop on chromosomes in leukemia. Cancer Genet Cytogenet 73:1, 1994
28. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E: Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 9:965, 1995
29. Fonatsch C, Gudat H, Lengfelder E, Wandt H, Silling-Engelhardt G, Ludwig W-D, Thiel E, Freund M, Bodenstein H, Schwieder G, Grüneisen A, Aul C, Schnittger S, Rieder H, Haase D, Hild F: Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21q26). Leukemia 8:1318, 1994
30. Slovak ML, Traweek ST, Willman CL, Head DR, Kopecky KJ, Magenis RE, Appelbaum FR, Forman SJ. Trisomy 11: An association with stem/progenitor cell immunophenotype. Br J Haematol 90:266, 1995